Connect with us
CGIF-10th-Year-Anniversary

Health

Thailand’s medical tourism sector faces challenge from other countries

Political instability and sharp gains in the baht are having a profound effect on the medical tourism industry, turning regional competitors into a major challenge, say international experts.

Boris Sullivan

Published

on

Political instability and sharp gains in the baht are having a profound effect on the medical tourism industry, turning regional competitors into a major challenge, say international experts.

They said the sector must develop a focused strategy and especially public-private partnerships, an area in which Thailand still lags neighbouring countries, especially Singapore.

Thailand, Singapore, Malaysia and India have emerged as the four major medical tourism players in Asia. Even though Thailand has the highest number of foreign patient arrivals, Singapore has a very fast growth rate, said Paul Tiffany, a business consultant.

Medical device

The strengthening baht has made Thailand's medical tourism industry less competitive in terms of costs, especially compared with India.

He said despite Thailand’s competitive advantages over its rivals, political uncertainty is prompting foreign patients to have second thoughts about coming here for treatment.

Research also suggests this to be a market that is highly influenced by perceptions of political unrest. Once problems develop, demand declines very rapidly and takes a long time to recover.

“For example, medical tourism [in the US] collapsed after 9/11 and took a minimum of five years to recover to where it had been in 2000,” said Dr Tiffany.

The strengthening baht has made Thailand’s medical tourism industry less competitive in terms of costs, especially compared with India.

“With the baht now trading above 30 to the dollar, the cost of medical treatment in Thailand has risen substantially over the past couple of years,” said Dr Tiffany, a visiting professor at Chulalongkorn University’s Sasin Graduate Institute of Business Administration.

via Bangkok Post : Thailand faces challenge from rivals

Comments

Companies

Thai Firm to produce 200 million doses of Covid-19 vaccine

Thai Firm Siam Bioscience Joins with AstraZeneca to Make COVID-19 Vaccine for Southeast Asia and says it will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year.

Olivier Languepin

Published

on

Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.

(more…)
Continue Reading

Health

The Latest on Covid-19 in Southeast Asia

Even in Southeast Asia, which has fared comparatively well in minimizing deaths, economies have either ground to a halt or deeply contracted due to the region’s reliance on exports and tourism.

Pr News

Published

on

By

It would be an understatement to describe 2020 as a challenging year. Coronavirus swept the globe and over 1.6 million people have died from the disease.

(more…)
Continue Reading

Health

Covid-19 is not the biggest health crisis in Thailand

For many years, Thailand has earned notoriety in the area of road fatalities: Thailand’s roads are the deadliest in Southeast Asia and among the worst in the world, according to the World Health Organisation

Avatar

Published

on

If we go by the number of deaths, the coronavirus is not the country’s biggest health public health problem. Road accidents are.

(more…)
Continue Reading
Advertisement

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,413 other subscribers

Trending